Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hospital Acquired Infection Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hospital Acquired Infection Treatmentmarket, defines the market attractiveness level of Hospital Acquired Infection Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hospital Acquired Infection Treatment industry, describes the types of Hospital Acquired Infection Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hospital Acquired Infection Treatment market and the development prospects and opportunities of Hospital Acquired Infection Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hospital Acquired Infection Treatment market in Chapter 13.
By Player:
GlaxoSmithKline plc
Aridis Pharmaceuticals, Inc
F Hoffmann-La Roche Ltd
AstraZeneca plc
Eli Lilly and Company
Daiichi Sankyo, Inc
Cepheid
Abbott Laboratories
Merck & Co, Inc
Bayer AG
Pfizer Inc
Johnson & Johnson Services, Inc
Cipla Inc
Bristol-Myers Squibb Company
Astellas Pharma Inc
By Type:
Antibacterial
Antiviral
Antifungal Treatment
Antiparasitic
Antiprotozoal
Anti-TB Treatment
By End-User:
Urinary Tract Infection
Ventilator-Associated Pneumonia
Bloodstream Infection
Surgical Site Infection
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hospital Acquired Infection Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hospital Acquired Infection Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hospital Acquired Infection Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hospital Acquired Infection Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hospital Acquired Infection Treatment Market Analysis and Outlook to 2022
-
7.1 Global Hospital Acquired Infection Treatment Consumption (2017-2022)
-
7.2 United States Hospital Acquired Infection Treatment Consumption (2017-2022)
-
7.3 Europe Hospital Acquired Infection Treatment Consumption (2017-2022)
-
7.4 China Hospital Acquired Infection Treatment Consumption (2017-2022)
-
7.5 Japan Hospital Acquired Infection Treatment Consumption (2017-2022)
-
7.6 India Hospital Acquired Infection Treatment Consumption (2017-2022)
-
7.7 South Korea Hospital Acquired Infection Treatment Consumption (2017-2022)
8 Region and Country-wise Hospital Acquired Infection Treatment Market Analysis and Outlook to 2028
-
8.1 Global Hospital Acquired Infection Treatment Consumption Forecast (2022-2028)
-
8.2 United States Hospital Acquired Infection Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Hospital Acquired Infection Treatment Consumption Forecast (2022-2028)
-
8.4 China Hospital Acquired Infection Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Hospital Acquired Infection Treatment Consumption Forecast (2022-2028)
-
8.6 India Hospital Acquired Infection Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Hospital Acquired Infection Treatment Consumption Forecast (2022-2028)
9 Global Hospital Acquired Infection Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Hospital Acquired Infection Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibacterial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiviral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antifungal Treatment Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Antiparasitic Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Antiprotozoal Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Anti-TB Treatment Consumption and Growth Rate (2017-2022)
-
9.2 Global Hospital Acquired Infection Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ventilator-Associated Pneumonia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Bloodstream Infection Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Surgical Site Infection Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Hospital Acquired Infection Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Hospital Acquired Infection Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antibacterial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antifungal Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Antiparasitic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Antiprotozoal Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Anti-TB Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hospital Acquired Infection Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ventilator-Associated Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Bloodstream Infection Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Surgical Site Infection Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Hospital Acquired Infection Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hospital Acquired Infection Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hospital Acquired Infection Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hospital Acquired Infection Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hospital Acquired Infection Treatment Market Competitive Analysis
-
14.1 GlaxoSmithKline plc
-
14.1.1 GlaxoSmithKline plc Company Details
-
14.1.2 GlaxoSmithKline plc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline plc Hospital Acquired Infection Treatment Product and Service
-
14.2 Aridis Pharmaceuticals, Inc
-
14.2.1 Aridis Pharmaceuticals, Inc Company Details
-
14.2.2 Aridis Pharmaceuticals, Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Aridis Pharmaceuticals, Inc Hospital Acquired Infection Treatment Product and Service
-
14.3 F Hoffmann-La Roche Ltd
-
14.3.1 F Hoffmann-La Roche Ltd Company Details
-
14.3.2 F Hoffmann-La Roche Ltd Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 F Hoffmann-La Roche Ltd Hospital Acquired Infection Treatment Product and Service
-
14.4 AstraZeneca plc
-
14.4.1 AstraZeneca plc Company Details
-
14.4.2 AstraZeneca plc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca plc Hospital Acquired Infection Treatment Product and Service
-
14.5 Eli Lilly and Company
-
14.5.1 Eli Lilly and Company Company Details
-
14.5.2 Eli Lilly and Company Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eli Lilly and Company Hospital Acquired Infection Treatment Product and Service
-
14.6 Daiichi Sankyo, Inc
-
14.6.1 Daiichi Sankyo, Inc Company Details
-
14.6.2 Daiichi Sankyo, Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Daiichi Sankyo, Inc Hospital Acquired Infection Treatment Product and Service
-
14.7 Cepheid
-
14.7.1 Cepheid Company Details
-
14.7.2 Cepheid Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cepheid Hospital Acquired Infection Treatment Product and Service
-
14.8 Abbott Laboratories
-
14.8.1 Abbott Laboratories Company Details
-
14.8.2 Abbott Laboratories Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Abbott Laboratories Hospital Acquired Infection Treatment Product and Service
-
14.9 Merck & Co, Inc
-
14.9.1 Merck & Co, Inc Company Details
-
14.9.2 Merck & Co, Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck & Co, Inc Hospital Acquired Infection Treatment Product and Service
-
14.10 Bayer AG
-
14.10.1 Bayer AG Company Details
-
14.10.2 Bayer AG Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bayer AG Hospital Acquired Infection Treatment Product and Service
-
14.11 Pfizer Inc
-
14.11.1 Pfizer Inc Company Details
-
14.11.2 Pfizer Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pfizer Inc Hospital Acquired Infection Treatment Product and Service
-
14.12 Johnson & Johnson Services, Inc
-
14.12.1 Johnson & Johnson Services, Inc Company Details
-
14.12.2 Johnson & Johnson Services, Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Johnson & Johnson Services, Inc Hospital Acquired Infection Treatment Product and Service
-
14.13 Cipla Inc
-
14.13.1 Cipla Inc Company Details
-
14.13.2 Cipla Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Cipla Inc Hospital Acquired Infection Treatment Product and Service
-
14.14 Bristol-Myers Squibb Company
-
14.14.1 Bristol-Myers Squibb Company Company Details
-
14.14.2 Bristol-Myers Squibb Company Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Bristol-Myers Squibb Company Hospital Acquired Infection Treatment Product and Service
-
14.15 Astellas Pharma Inc
-
14.15.1 Astellas Pharma Inc Company Details
-
14.15.2 Astellas Pharma Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Astellas Pharma Inc Hospital Acquired Infection Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hospital Acquired Infection Treatment
-
Figure Hospital Acquired Infection Treatment Picture
-
Table Global Hospital Acquired Infection Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hospital Acquired Infection Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hospital Acquired Infection Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hospital Acquired Infection Treatment Consumption by Country (2017-2022)
-
Figure United States Hospital Acquired Infection Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Hospital Acquired Infection Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Hospital Acquired Infection Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Hospital Acquired Infection Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Hospital Acquired Infection Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hospital Acquired Infection Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Acquired Infection Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Hospital Acquired Infection Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hospital Acquired Infection Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hospital Acquired Infection Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hospital Acquired Infection Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hospital Acquired Infection Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hospital Acquired Infection Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibacterial Consumption and Growth Rate (2017-2022)
-
Figure Global Antiviral Consumption and Growth Rate (2017-2022)
-
Figure Global Antifungal Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Antiparasitic Consumption and Growth Rate (2017-2022)
-
Figure Global Antiprotozoal Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-TB Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Ventilator-Associated Pneumonia Consumption and Growth Rate (2017-2022)
-
Figure Global Bloodstream Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Surgical Site Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Antibacterial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antifungal Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiparasitic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiprotozoal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-TB Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ventilator-Associated Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bloodstream Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgical Site Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hospital Acquired Infection Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hospital Acquired Infection Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Hospital Acquired Infection Treatment Product and Service
-
Table Aridis Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Aridis Pharmaceuticals, Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aridis Pharmaceuticals, Inc Hospital Acquired Infection Treatment Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Hospital Acquired Infection Treatment Product and Service
-
Table AstraZeneca plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca plc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca plc Hospital Acquired Infection Treatment Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Hospital Acquired Infection Treatment Product and Service
-
Table Daiichi Sankyo, Inc (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo, Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo, Inc Hospital Acquired Infection Treatment Product and Service
-
Table Cepheid (Foundation Year, Company Profile and etc.)
-
Table Cepheid Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cepheid Hospital Acquired Infection Treatment Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Hospital Acquired Infection Treatment Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Hospital Acquired Infection Treatment Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Hospital Acquired Infection Treatment Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Hospital Acquired Infection Treatment Product and Service
-
Table Johnson & Johnson Services, Inc (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Services, Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Services, Inc Hospital Acquired Infection Treatment Product and Service
-
Table Cipla Inc (Foundation Year, Company Profile and etc.)
-
Table Cipla Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Inc Hospital Acquired Infection Treatment Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Hospital Acquired Infection Treatment Product and Service
-
Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Inc Hospital Acquired Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Hospital Acquired Infection Treatment Product and Service
-
